V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10465961 | 10072014 | 1.73 | 65.2 | null | 2022-01-18 | 2022-01-19 | Trial Unspecified | 01 | null | PACLITAXEL | 100117941 |
| 10465966 | 10072015 | 1.74 | 83 | 03 | null | 2020-02-20 | Trial Unspecified | 01 | N | PACLITAXEL | 100011266 |
| 10466110 | 10072018 | 1.53 | 0 | null | null | 2020-12-14 | Abiraterone | 02 | null | ABIRATERONE | 101679328 |
| 10466128 | 10072019 | 1.73 | 85 | Palliative (P) | 2020-10-20 | 2020-10-20 | Abiraterone | 02 | N | ABIRATERONE | 100100846 |
| 10466645 | 10072022 | 1.6 | null | Palliative (P) | 2021-05-20 | 2021-06-03 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 100970607 |
| 10468518 | 10072033 | 1.69 | 90 | Palliative (P) | 2020-01-21 | 2020-12-25 | Abiraterone | 02 | N | ABIRATERONE | 100909344 |
| 10468622 | 10072034 | null | null | null | 2022-03-19 | 2022-03-28 | Abiraterone | 02 | null | ABIRATERONE | 101344751 |
| 10468968 | 10072036 | 1.57 | 54.5 | Adjuvant (A) | 2022-04-12 | 2022-05-15 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 100059850 |
| 10469141 | 10072037 | 1.66 | 77 | Palliative (P) | 2021-06-15 | 2021-08-14 | null | null | N | TRIAL UNSPECIFIED | 101563653 |
| 10470127 | 10072040 | 1.8 | 0 | null | 2018-01-26 | 2018-02-09 | Hydroxycarbamide | 2 | null | HYDROXYCARBAMIDE | 101514731 |
| 10470330 | 10072041 | null | 76 | null | 2021-11-24 | 2021-11-27 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 100449604 |
| 10470927 | 10072042 | 1.81 | 64 | null | 2022-04-05 | 2022-04-05 | Hydroxycarbamide | 01 | null | TRIAL UNSPECIFIED | 100582492 |
| 10471236 | 10072046 | 1.78 | null | null | null | 2022-05-26 | Trial Unspecified | 01 | null | ABIRATERONE | 101540971 |
| 10471295 | 10072047 | 1.82 | 97.2 | null | 2020-08-06 | 2021-04-12 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | PACLITAXEL | 100908442 |
| 10472268 | 10072049 | 1.58 | 62.4 | null | 2020-11-30 | 2020-12-11 | Paclitaxel (2 or 3 weekly) | 02 | null | PACLITAXEL | 100556910 |
| 10472593 | 10072050 | 1.65 | 55 | null | 2022-04-12 | 2022-04-20 | PACLITAXEL | 02 | null | PACLITAXEL | 100229655 |
| 10472625 | 10072051 | 0 | 66.2 | null | 2021-12-21 | 2022-02-07 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 100937102 |
| 10473300 | 10072054 | 1.74 | null | null | 2021-10-14 | 2021-10-28 | Abiraterone | 02 | null | ABIRATERONE | 100676385 |
| 10474605 | 10072061 | 1.7 | 80 | null | null | 2017-08-26 | PACLITAXEL | 02 | null | PACLITAXEL | 101406012 |
| 10474775 | 10072062 | 1.62 | 51.6 | Curative (C) | null | 2020-05-04 | null | null | N | TRIAL UNSPECIFIED | 100544205 |
| 10474959 | 10072063 | 1.64 | 72.5 | 03 | 2020-03-06 | 2020-03-13 | DARATUMUMAB | 02 | N | BENDAMUSTINE + RITUXIMAB | 100133294 |
| 10475839 | 10072065 | 1.77 | 109.7 | 03 | 2019-12-17 | 2019-12-17 | Avelumab | 02 | N | CAPECITABINE + OXALIPLATIN | 101566247 |
| 10476007 | 10072066 | null | 75.7 | null | 2022-01-15 | 2022-01-29 | Avelumab | 02 | null | DARATUMUMAB | 101783671 |
| 10476167 | 10072067 | 1.56 | 104.9 | Adjuvant (A) | 2018-05-30 | 2018-06-03 | Avelumab | 02 | N | CEMIPLIMAB | 101822073 |
| 10476208 | 10072068 | 1.58 | 73.9 | null | 2021-08-23 | 2021-09-09 | FLUOROURACIL + OXALIPLATIN | 02 | null | FLUOROURACIL + IRINOTECAN | 101219215 |
| 10476349 | 10072069 | 1.68 | 84.6 | 03 | 2021-06-05 | 2021-08-01 | Avelumab | 02 | null | FLUOROURACIL + IRINOTECAN | 100795698 |
| 10476870 | 10072070 | 1.49 | 54.2 | null | 2022-03-26 | 2022-03-31 | RUXOLITINIB | 02 | null | RUXOLITINIB | 101542939 |
| 10476979 | 10072071 | 1.72 | 83 | null | 2020-04-08 | 2020-04-10 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100546780 |
| 10478018 | 10072074 | 1.5 | 75.6 | Adjuvant (A) | 2020-06-13 | 2020-07-06 | Avelumab | 02 | N | CARBOPLATIN + GEMCITABINE | 101065849 |
| 10478223 | 10072075 | null | 109.7 | Disease modification (D) | 2021-03-05 | 2021-03-21 | RUXOLITINIB | 02 | null | RUXOLITINIB | 100055196 |
| 10478666 | 10072077 | 1.66 | 72.2 | null | 2019-12-28 | 2020-04-12 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100445526 |
| 10479358 | 10072079 | 0 | 88.4 | null | 2018-11-25 | 2018-12-15 | Avelumab | 02 | null | NIVOLUMAB | 100276862 |
| 10479827 | 10072080 | 1.66 | 77 | Palliative (P) | 2022-03-07 | 2022-03-10 | Avelumab | 02 | N | AVELUMAB | 101459334 |
| 10480215 | 10072082 | 1.9 | 53 | Neo-adjuvant (N) | 2021-05-27 | 2021-06-01 | Venetoclax | 02 | N | VENETOCLAX | 100454175 |
| 10480584 | 10072083 | 1.79 | 79.6 | null | 2021-06-28 | 2021-12-13 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100826685 |
| 10480685 | 10072084 | 1.7 | 121.9 | null | 2018-05-19 | 2018-06-02 | Avelumab | null | null | NIVOLUMAB | 101028572 |
| 10480995 | 10072085 | 1.76 | 98 | null | 2021-06-03 | 2021-06-12 | Avelumab | 02 | null | DARATUMUMAB | 101534738 |
| 10481308 | 10072086 | 1.75 | 109.4 | null | 2019-11-18 | 2020-04-07 | Irinotecan + Modified De Gramont | 02 | null | FLUOROURACIL + IRINOTECAN | 101289950 |
| 10001985 | 10072089 | 1.56 | 68.3 | null | 2018-01-25 | 2018-02-16 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 101801414 |
| 10017166 | 10072090 | 1.57 | 102.2 | null | 2019-09-07 | 2020-01-03 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100287119 |
| 10018584 | 10072091 | 1.85 | 70.4 | null | 2022-04-03 | 2022-04-13 | DARATUMUMAB | 02 | null | DARATUMUMAB | 101088419 |
| 10037227 | 10072092 | 1.61 | 76.5 | Adjuvant (A) | 2020-07-01 | 2021-11-25 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101371464 |
| 10042327 | 10072093 | 1.61 | 45.8 | Palliative (P) | 2019-09-11 | 2019-10-02 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 101033870 |
| 10051750 | 10072095 | 1.67 | 71.4 | Palliative (P) | 2020-05-09 | 2020-08-04 | Avelumab | 02 | N | TRASTUZUMAB | 100309116 |
| 10064100 | 10072097 | 1.74 | 91.4 | Curative (C) | 2020-09-13 | 2020-10-03 | DARATUMUMAB | null | N | DARATUMUMAB | 100807441 |
| 10075178 | 10072098 | null | 49.9 | null | 2021-04-17 | 2021-05-01 | Avelumab | 02 | null | AVELUMAB | 101049512 |
| 10091197 | 10072099 | 1.49 | 61 | Palliative (P) | 2021-07-13 | 2021-09-27 | Venetoclax | 02 | N | VENETOCLAX | 101301313 |
| 10103476 | 10072101 | 1.61 | 65 | null | 2022-05-10 | 2022-05-21 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 100440302 |
| 10121867 | 10072102 | 1.66 | 95 | null | 2020-07-04 | 2020-07-16 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 101375454 |
| 10138617 | 10072103 | 1.85 | 61 | null | 2018-03-09 | 2018-03-30 | Bendamustine+Rituximab (1st Course) | 02 | N | BENDAMUSTINE + RITUXIMAB | 101005405 |